Innoviva, Inc. (INVA)
22.18
+0.03
(+0.14%)
USD |
NASDAQ |
Mar 17, 10:29
Innoviva Shareholders Equity (Quarterly) : 1.173B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 52.61B |
| Nektar Therapeutics | 89.83M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Oramed Pharmaceuticals, Inc. | 203.28M |
| Theravance Biopharma, Inc. | 232.68M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.635B |
| Total Liabilities (Quarterly) | 462.32M |
| Debt to Equity Ratio | 0.2294 |
| Current Ratio | 14.64 |
| Net Debt Paydown Yield | 2.44% |